Literature DB >> 27553702

Fatigue in patients with erythema migrans.

Gary P Wormser1, Praveen Sudhindra2, Eliana Lopez2, Lisa Patel2, Sara Rezai2, Aaron D Brumbaugh2, Donna McKenna2, Carol Scavarda2, Eugene D Shapiro3, Carol L Karmen4, Paul Visintainer5.   

Abstract

Fatigue is a common symptom in patients with Lyme disease. The purpose of this study was to characterize fatigue in untreated adult patients presenting with erythema migrans. Selected variables were assessed to determine if any correlated with the presence or severity of fatigue. Fatigue was assessed on the day of the evaluation by a Visual Analogue Scale (VAS), over the past 14days by the 11-item Fatigue Severity Scale (FSS-11) and over the past 28days based on a question from the 36-item Short Form General Health Survey version 2. Fifty-one patients with erythema migrans whose mean age was 49.8years, and 33 (64.7%) of whom were male, were evaluated in this study. The 3 measures of fatigue were positively correlated with one another (P≤0.01). Twenty-six (51%) had fatigue based on a VAS score above 0. Ten (19.6%) had severe fatigue based on an FSS-11 score of ≥4. The strongest correlate for higher fatigue scores was having a greater total number of symptoms. Based on the FSS-11 assessment tool, approximately 20% of early Lyme patients have severe fatigue. Having a high total number of symptoms was associated with both the presence and severity of fatigue. Because prior studies have demonstrated the presence of elevated levels of proinflammatory cytokines and other molecules in the serum of highly symptomatic patients with erythema migrans, the symptom of fatigue in early Lyme disease may be a component of what has been referred to as the acute sickness response.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute sickness response; Borrelia burgdorferi; Fatigue; Lyme disease

Mesh:

Year:  2016        PMID: 27553702      PMCID: PMC5061607          DOI: 10.1016/j.diagmicrobio.2016.07.026

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  21 in total

1.  Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.

Authors:  Klemen Strle; Junghee J Shin; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2012-05

2.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

3.  Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease.

Authors:  G P Wormser; D Liveris; J Nowakowski; R B Nadelman; L F Cavaliere; D McKenna; D Holmgren; I Schwartz
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

4.  Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans.

Authors:  U Vollmer-Conna; C Fazou; B Cameron; H Li; C Brennan; L Luck; T Davenport; D Wakefield; I Hickie; A Lloyd
Journal:  Psychol Med       Date:  2004-10       Impact factor: 7.723

5.  Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Authors:  Erica Weitzner; Donna McKenna; John Nowakowski; Carol Scavarda; Rhea Dornbush; Susan Bittker; Denise Cooper; Robert B Nadelman; Paul Visintainer; Ira Schwartz; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

Review 6.  Does this patient have erythema migrans?

Authors:  Carrie D Tibbles; Jonathan A Edlow
Journal:  JAMA       Date:  2007-06-20       Impact factor: 56.272

7.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

Review 8.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

9.  Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Authors:  Gary P Wormser; Maria E Aguero-Rosenfeld; Mary E Cox; John Nowakowski; Robert B Nadelman; Diane Holmgren; Donna McKenna; Susan Bittker; Lois Zentmaier; Denise Cooper; Dionysios Liveris; Ira Schwartz; Harold W Horowitz
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

10.  Genetic associations of fatigue and other symptom domains of the acute sickness response to infection.

Authors:  B Piraino; U Vollmer-Conna; A R Lloyd
Journal:  Brain Behav Immun       Date:  2011-12-29       Impact factor: 7.217

View more
  6 in total

Review 1.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

2.  Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months.

Authors:  Gary P Wormser; Donna McKenna; Carol L Karmen; Keith D Shaffer; Jesse H Silverman; John Nowakowski; Carol Scavarda; Eugene D Shapiro; Paul Visintainer
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

3.  Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment.

Authors:  Gary P Wormser; Donna McKenna; Eliana Jacobson; Elayna M Shanker; Keith D Shaffer; Carol Scavarda; Paul Visintainer
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Co-infections in Persons with Early Lyme Disease, New York, USA.

Authors:  Gary P Wormser; Donna McKenna; Carol Scavarda; Denise Cooper; Marc Y El Khoury; John Nowakowski; Praveen Sudhindra; Alexander Ladenheim; Guiqing Wang; Carol L Karmen; Valerie Demarest; Alan P Dupuis; Susan J Wong
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

5.  Post-treatment Lyme disease symptoms score: Developing a new tool for research.

Authors:  Siu P Turk; Keith Lumbard; Kelly Liepshutz; Carla Williams; Linden Hu; Kenneth Dardick; Gary P Wormser; Joshua Norville; Carol Scavarda; Donna McKenna; Dean Follmann; Adriana Marques
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

6.  Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study.

Authors:  Florence Brellier; Mar Pujades-Rodriguez; Emma Powell; Kathleen Mudie; Eliana Mattos Lacerda; Luis Nacul; Kevin Wing
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.